Ludmila M. Kuzenkova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening

Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 12, 2026

Duchenne Muscular Dystrophy in the Republic of North Ossetia-Alania: Epidemiological Study, Diagnostic Issues, and Treatment Prospects.

Duchenne Muscular Dystrophy in the Republic of North Ossetia-Alania: Epidemiological Study, Diagnostic Issues, and Treatment Prospects.

Journal: Genes

Published: October 27, 2025

In Search of Spinal Muscular Atrophy Disease Modifiers.

In Search of Spinal Muscular Atrophy Disease Modifiers.

Journal: International journal of molecular sciences

Published: September 13, 2024

Genotype-Phenotype Correlations in 293 Russian Patients with Causal Fabry Disease Variants.

Genotype-Phenotype Correlations in 293 Russian Patients with Causal Fabry Disease Variants.

Journal: Genes

Published: September 22, 2023

Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian Population.

Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian Population.

Journal: International journal of molecular sciences

Published: September 05, 2022

Multilevel botulinum toxin treatment in severe spastic forms of cerebral palsy (GMFCS IV-V)

Multilevel botulinum toxin treatment in severe spastic forms of cerebral palsy (GMFCS IV-V)

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 18, 2021

Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience

Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 14, 2020

Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years

Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: July 18, 2020

Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy

Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: December 22, 2017

Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid

Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 23, 2017

The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy

The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 17, 2017

Evaluation of physical development in children with classical phenylketonuria

Evaluation of physical development in children with classical phenylketonuria

Journal: Voprosy pitaniia

Published: February 05, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026